Nordea Innovation Seminar

Gunilla Osswald, CEO, presented BioArctic at Nordea Innovation Seminar in Stockholm.

Redeye Neurology Seminar

Gunilla Osswald, CEO, presents BioArctic and participates in a panel discussion at the Redeye Neurology Seminar in Stockholm, Sweden. BioArctic presentation (in Swedish) Panel discussion (in ...

Redeye – CEO interview

Get to know BioArctic’s CEO Gunilla Osswald, an interview by Redeye’s Equity Analyst Eddie Palmgren. Video (in Swedish).

Redeye Growth Day Presentation and Interview with EFN

Gunilla Osswald, CEO, presented BioArctic at the Redeye Growth Day in Stockholm, Sweden. Video (in Swedish) EFN Interview (in Swedish) https://www.efn.se/bors-finans/biorctic-ser-framgangar-inom-samtliga-omraden/

Redeye – CEO interview

BioArctic announced on February 4 that Eisai will initiate Phase 3 confirmatory study with BAN2401 in early Alzheimer’s Disease. Interview with CEO Gunilla Osswald here.

Interview with Gunilla Osswald, CEO

Gunilla Osswald, CEO, was interviewed by Klas Palin, life science analyst at Redeye, in Stockholm on December 14, 2018.

Stora Aktiedagen in Stockholm

Gunilla Osswald, CEO, presented BioArctic at the “Stora Aktiedagen” in Stockholm, Sweden, on November 26.

Biotech and Money in London

Gunilla Osswald, CEO, presented BioArctic at Biotech and Money, Investival Showcase, on November 13 in London.

Redeye CNS Biotech Seminar

Gunilla Osswald, PhD, CEO, presents BioArctic at Redeye CNS Biotech Seminar in Stockholm, Sweden.

Redeye Growth Day

Gunilla Osswald, PhD, CEO, presents BioArctic at Redeye Growth Day in Stockholm, Sweden.

Carnegie Healthcare Seminar 2018

Gunilla Osswald, PhD, CEO, presented BioArctic at the Carnegie Healthcare Seminar 2018 on March 14 in Stockholm, Sweden.

DNB Nordic Healthcare Conference

Gunilla Osswald, CEO of BioArctic AB, presented the company at DNB Nordic Healthcare Conference in Oslo, Norway, on December 14, 2017.

Evercore ISI in New York

Gunilla Osswald, PhD, CEO, and Lars Lannfelt, Professor, MD, Senior Advisor and Co-Founder presented BioArctic at Evercore ISI in New York. The lunch meeting took place ...